Fujirebio Taiwan Inc. was founded in 1981, more than 30 years ago in Taiwan. Our parent company, Fujirebio Inc., a leading international healthcare company that conceives, develops, produces and markets high quality in vitro diagnostics (IVD) testing solutions worldwide.


Fujirebio Inc. (富士レビオ株式会社) was founded in 1950 under the name Fujizoki Pharmaceutical Co., Ltd. In 1983 the name of the company was changed to Fujirebio Inc. This name is a fusion of the name FUJI, from Japan's famous icon, Mt. Fuji, RE from the English word "revival", and BIO from the Greek word bios, which means "life".

Fujirebio Taiwan specializes in the manufacturing of in vitro diagnostics (IVD) testing reagents and controls distributed throughout the Taiwan, Korea, Singapore and Europe. With GMP, ISO9001, and ISO13485 certificated plant, close to 8,800 square meters of manufacturing space, we provide high quality products such as particle agglutination tests(SERODIA-TPPA), which have been fully used by all Blood Centers in Taiwan since 2006, until now it has still been one of standards for evaluating the titer of syphilis in Taiwan. Fujirebio Taiwan also imports high quality IVD products from Fujirebio Inc. (Japan) and distributes in Taiwan market.

In order to meet our customer's needs, in year 2011, a fully automated chemiluminescent enzyme immunoassay (CLEIA) system, was launched in Taiwan. Today, the high sensitivity CL reagents are available and they cover areas such as infectious diseases, oncology,…(read more).

As a member of the Miraca group, we will continue contributing to the global healthcare through clinical diagnostics, and will use our resources to improve the quality of products that aid healthcare professionals in the treatment of human disease.

Corporate Philosophy

Contributing to Global Healthcare through the Creation of New Values with Respect for Human Life and Commitment to People's Health.

Management Policy